Burcak Beser - Oncotelic Therapeutics CTO Division

Insider

Burcak Beser is CTO Division of Oncotelic Therapeutics
Phone650 635 7000
Webhttps://www.oncotelic.com

Oncotelic Therapeutics Management Efficiency

The company has return on total asset (ROA) of (0.1323) % which means that it has lost $0.1323 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.4967 %, meaning that it created $0.4967 on every $100 dollars invested by stockholders. Oncotelic Therapeutics' management efficiency ratios could be used to measure how well Oncotelic Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.
Oncotelic Therapeutics currently holds 9.8 M in liabilities with Debt to Equity (D/E) ratio of 0.4, which is about average as compared to similar companies. Oncotelic Therapeutics has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Oncotelic Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, Oncotelic Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Oncotelic Therapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Oncotelic to invest in growth at high rates of return. When we think about Oncotelic Therapeutics' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

MSc MScCellectis SA
54
Kyung NamWortmanCellectis SA
53
PharmD BigoraProcessa Pharmaceuticals
65
Robert FloydProcessa Pharmaceuticals
68
Dr MBACellectis SA
46
Valerie CrosCellectis SA
N/A
Ann LeenAllovir
48
Agustin MDAllovir
60
Brett HagenAllovir
52
Jean EpinatCellectis SA
N/A
Jeroen BeekAllovir
60
PharmD YoungProcessa Pharmaceuticals
72
Pascalyne WilsonCellectis SA
N/A
Dana MBAAllovir
48
Daniel RyweckSilo Pharma
59
Diana MDAllovir
53
Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing drugs for the treatment of orphan oncology indications. It also develops OXi4503 for the treatment of acute myeloid leukemia and myelodysplastic syndromes and CA4P for the treatment of advanced metastatic melanoma. Oncotelic Therapeutics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 16 people. Oncotelic Therapeutics [OTLC] is traded as part of a regulated electronic over-the-counter service offered by the NASD. Oncotelic Therapeutics is listed under Pharmaceutical Products category by Fama And French industry classification.

Management Performance

Oncotelic Therapeutics Leadership Team

Elected by the shareholders, the Oncotelic Therapeutics' board of directors comprises two types of representatives: Oncotelic Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Oncotelic. The board's role is to monitor Oncotelic Therapeutics' management team and ensure that shareholders' interests are well served. Oncotelic Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Oncotelic Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
Vuong Trieu, Chairman CEO
Seymour MD, Chief Officer
Larn Hwang, Chief Officer
Chulho Park, Consultant
Burcak Beser, CTO Division
III BA, Chief Director
Amit Shah, Chief Officer
Saranjit Saund, CBO Division

Oncotelic Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Oncotelic Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Consideration for investing in Oncotelic OTC Stock

If you are still planning to invest in Oncotelic Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oncotelic Therapeutics' history and understand the potential risks before investing.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios